6-Bromo-2-hydroxy-3-methoxybenzaldehyde (CAS No 20035-41-0) is an important compound in biomedical research often studied for its potential therapeutic applications Originating from modifications of natural phenolic compounds it is investigated for its role in modulating biochemical pathways particularly those involving oxidation-reduction reactions This compound exhibits activity in the nanomolar to low micromolar range indicating strong efficacy in vitro It is commonly applied in cell models such as cancer cell lines to evaluate its effects on proliferation and apoptosis and in animal studies for understanding its pharmacokinetics Additionally 6-Bromo-2-hydroxy-3-methoxybenzaldehyde is frequently used in drug screening assays to identify potential candidates for further development Experimental concentrations typically depend on the specific research design ensuring versatility and adaptability across different experimental frameworks